Abstract
Cellular reprogramming is a process by which adult differentiated cells lose their identity and are converted into pluripotent stem cells, known as induced pluripotent stem (iPS) cells. This process can be achieved in vitro and in vivo and is relevant for many fields including regenerative medicine and cancer. Cellular reprogramming is commonly induced by the ectopic expression of a transcription factor cocktail composed by Oct4, Sox2, Klf4, and Myc (abbreviated as OSKM), and its efficiency and kinetics are strongly dependent on the presence of Myc. Here, we describe a versatile method to study reprogramming in vivo based on the use of adeno-associated viral (AAV) vectors, which allows the targeting of specific organs and cell types. This method can be used to test Myc mutations or genes that may replace Myc, or be combined with different Myc regulators. In vivo reprogramming can be scored by the presence of teratomas and the isolation of in vivo iPS, thereby providing a simple surrogate for the function of Myc in dedifferentiation and stemness. Our protocol can be divided into five steps: (1) intravenous inoculation of AAV vectors; (2) monitoring the animals until the appearance of teratomas; (3) analysis of teratomas; (4) histopathological analysis of mouse organs; and (5) isolation of in vivo-generated iPS cells from teratomas, blood, and bone marrow. The information obtained by this in vivo testing platform may provide relevant information on the role of Myc in tissue regeneration, stemness, and cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676. https://doi.org/10.1016/j.cell.2006.07.024
Liu G, David BT, Trawczynski M, Fessler RG (2020) Advances in pluripotent stem cells: history, mechanisms, technologies, and applications. Stem Cell Rev Rep 16:3–32. https://doi.org/10.1007/s12015-019-09935-x
Abad M, Mosteiro L, Pantoja C et al (2013) Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502:340–345. https://doi.org/10.1038/nature12586
Ohnishi K, Semi K, Yamamoto T et al (2014) Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 156:663–677. https://doi.org/10.1016/j.cell.2014.01.005
Wernig M, Meissner A, Cassady JP, Jaenisch R (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2:10–12. https://doi.org/10.1016/j.stem.2007.12.001
Nakagawa M, Koyanagi M, Tanabe K et al (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101–106. https://doi.org/10.1038/nbt1374
Prieto J, Seo AY, León M et al (2018) MYC induces a hybrid energetics program early in cell reprogramming. Stem Cell Rep 11:1479–1492. https://doi.org/10.1016/j.stemcr.2018.10.018
Zviran A, Mor N, Rais Y et al (2019) Deterministic somatic cell reprogramming involves continuous transcriptional changes governed by Myc and epigenetic-driven modules. Cell Stem Cell 24:328–341. https://doi.org/10.1016/j.stem.2018.11.014
Meissner A, Wernig M, Jaenisch R (2007) Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25:1177–1181. https://doi.org/10.1038/nbt1335
Araki R, Hoki Y, Uda M et al (2011) Crucial role of C-Myc in the generation of induced pluripotent stem cells. Stem Cells 29:1362–1370. https://doi.org/10.1002/stem.685
Soufi A, Donahue G, Zaret KS (2012) Facilitators and impediments of the pluripotency reprogramming factors’ initial engagement with the genome. Cell 151:994–1004. https://doi.org/10.1016/j.cell.2012.09.045
Soufi A, Garcia MF, Jaroszewicz A et al (2015) Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161:555–568. https://doi.org/10.1016/j.cell.2015.03.017
Hirsch CL, Akdemir ZC, Wang L et al (2015) Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming. Genes Dev 29:803–816. https://doi.org/10.1101/gad.255109.114
Senís E, Mosteiro L, Wilkening S et al (2018) AAVvector-mediated in vivo reprogramming into pluripotency. Nat Commun 9:2651. https://doi.org/10.1038/s41467-018-05059-x
Wang D, Tai PWL, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18:358–378. https://doi.org/10.1038/s41573-019-0012-9
Srivastava A (2016) In vivo tissue-tropism of adeno-associated viral vectors. Curr Opin Virol 21:75–80. https://doi.org/10.1016/j.coviro.2016.08.003
Colella P, Ronzitti G, Mingozzi F (2018) Emerging issues in AAV-mediated in vivo gene therapy. Mol Ther Methods Clin Dev 8:87–104. https://doi.org/10.1016/j.omtm.2017.11.007
Conner DA (2001) Mouse embryo fibroblast (MEF) feeder cell preparation. Curr Protoc Mol Biol 51:23.2.1–23.2.7. https://doi.org/10.1002/0471142727.mb2302s51
Yardeni T, Eckhaus M, Morris HD (2011) Retro-orbital injections in mice. Lab Anim 40:155–160. https://doi.org/10.1038/laban0511-155
Rajarajan K, Engels MC, Wu SM (2012) Reprogramming of mouse, rat, pig, and human fibroblasts into iPS cells. Curr Protoc Mol Biol 97:23.15.1–23.15.32. https://doi.org/10.1002/0471142727.mb2315s97
Grimm D, Pandey K, Kay MA (2005) Adeno-associated virus vectors for short hairpin RNA expression. Methods Enzymol 392:381–405. https://doi.org/10.1016/S0076-6879(04)92023-X
Nakai H, Fuess S, Storm TA et al (2005) Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J Virol 79:214–224. https://doi.org/10.1128/jvi.79.1.214-224.2005
Weinmann J, Grimm D (2017) Next-generation AAV vectors for clinical use: an ever-accelerating race. Virus Genes 53:707–713. https://doi.org/10.1007/s11262-017-1502-7
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Senís, E., Mosteiro, L., Grimm, D., Abad, M. (2021). A Versatile In Vivo System to Study Myc in Cell Reprogramming. In: Soucek, L., Whitfield, J. (eds) The Myc Gene. Methods in Molecular Biology, vol 2318. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1476-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1476-1_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1475-4
Online ISBN: 978-1-0716-1476-1
eBook Packages: Springer Protocols